Published in J Neurosurg on December 01, 1993
Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev (2011) 2.22
Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res (2009) 2.09
The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol (2012) 1.84
Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol (2010) 1.69
Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells. Br J Pharmacol (1995) 0.85
Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cell Mol Neurobiol (1999) 0.81
The polycationic aminoglycosides modulate the vasoconstrictive effects of endothelin: relevance to cerebral vasospasm. Br J Pharmacol (2001) 0.79
Targeted over-expression of endothelin-1 in astrocytes leads to more severe brain damage and vasospasm after subarachnoid hemorrhage. BMC Neurosci (2013) 0.76
Inducible nitric oxide synthase (NOS-2) in subarachnoid hemorrhage: Regulatory mechanisms and therapeutic implications. Brain Circ (2016) 0.75
[D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm. Neurosurg Rev (2002) 0.75
De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry (2011) 4.91
Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med (1983) 2.63
Familial aggregation of Parkinson's disease in Iceland. N Engl J Med (2000) 2.41
The mutation rate in the human mtDNA control region. Am J Hum Genet (2000) 2.40
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. Am J Pathol (1982) 2.31
A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat Struct Biol (1997) 2.30
Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29
Ethics of population genomics research. Nature (1999) 2.20
Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med (1995) 2.15
The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain (2006) 1.97
A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke (1991) 1.97
Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet (2005) 1.91
Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery (1997) 1.90
Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med (2001) 1.89
Contribution of ADAM33 polymorphisms to the population risk of asthma. Thorax (2005) 1.76
Determination of contiguity of subclones using the polymerase chain reaction. Nucleic Acids Res (1988) 1.62
Population genomics: laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med (1998) 1.59
Etiology of cerebral vasospasm in primates. J Neurosurg (1991) 1.53
Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis (2010) 1.53
An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia (2001) 1.48
Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update (1998) 1.46
Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys. J Neurosurg (1992) 1.43
Genetic factors contribute to the risk of developing endometriosis. Hum Reprod (2002) 1.42
An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc Natl Acad Sci U S A (1989) 1.41
Scanning electron microscopy of normal and vasospastic monkey cerebrovascular smooth muscle cells. Neurosurgery (1991) 1.41
Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41
Distribution of S-100 protein outside the central nervous system. Brain Res (1982) 1.37
S-100 protein in human chondrocytes. Nature (1982) 1.35
Effects of posterior fossa decompression with and without duraplasty on Chiari malformation-associated hydromyelia. Neurosurgery (2000) 1.35
Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Mol Psychiatry (2004) 1.32
Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg (1988) 1.31
Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis. N Engl J Med (1985) 1.26
The phase shift hypothesis for bright light's therapeutic mechanism of action: theoretical considerations and experimental evidence. Psychopharmacol Bull (1987) 1.21
The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J Cell Biol (1990) 1.19
Circulating autoantibodies to the 200,000-dalton protein of neurofilaments in the serum of healthy individuals. Science (1985) 1.16
Immunohistochemistry of retinoblastomas in humans. Am J Ophthalmol (1984) 1.14
Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery (1993) 1.13
Identification of Gal(beta 1-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J Neurosci Res (1994) 1.11
Long-term prospective study of lumbosacral discectomy. J Neurosurg (1987) 1.09
Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf) (1990) 1.09
Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Mol Psychiatry (2011) 1.08
A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery (1995) 1.08
The genealogic approach to human genetics of disease. Cancer J (2001) 1.06
Genetic risk information for common diseases may indeed be already useful for prevention and early detection. Eur J Clin Invest (2010) 1.06
S-100 protein in granular cell tumors (granular cell myoblastomas). Cancer (1982) 1.05
Lung cancer: clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide. Cancer (1972) 1.04
Winter depression and the phase-shift hypothesis for bright light's therapeutic effects: history, theory, and experimental evidence. J Biol Rhythms (1988) 1.03
Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. J Neurochem (1992) 1.03
A role for the acetylcholine receptor-inducing protein ARIA in oligodendrocyte development. Proc Natl Acad Sci U S A (1994) 1.03
Morning vs evening light treatment for winter depression. Evidence that the therapeutic effects of light are mediated by circadian phase shifts. Arch Gen Psychiatry (1990) 1.02
Association between IL-1beta/TNF-alpha-induced glucocorticoid-sensitive changes in multiple gene expression and altered responsiveness in airway smooth muscle. Am J Respir Cell Mol Biol (2001) 1.01
A common biological basis of obesity and nicotine addiction. Transl Psychiatry (2013) 1.01
A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes. J Cell Biol (1988) 1.00
Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev (1991) 1.00
Expression of the oligodendrocyte-myelin glycoprotein by neurons in the mouse central nervous system. J Neurochem (1998) 1.00
Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol (1983) 1.00
Risk level, knowledge, and preventive behavior for human papillomaviruses among sexually active college women. J Am Coll Health (1992) 0.99
Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes. Br J Dermatol (2003) 0.99
Distribution of the neuronal specific protein, 14-3-2, in central nervous system lesions of tuberous sclerosis. Acta Neuropathol (1981) 0.98
Release of substance P from peripheral nerve terminals following electrical stimulation of the sciatic nerve. Brain Res (1985) 0.97
Gangliosides of human spinal cord: aberrant composition of cords from patients with amyotrophic lateral sclerosis. J Neurosci Res (1984) 0.97
Distribution of glial fibrillary acidic protein in central nervous system lesions of tuberous sclerosis. Acta Neuropathol (1980) 0.95
Prospective study of 100 lumbosacral discectomies. J Neurosurg (1979) 0.94
The complete cDNA sequence of human hexabrachion (Tenascin). A multidomain protein containing unique epidermal growth factor repeats. J Biol Chem (1991) 0.94
Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol (1990) 0.94
Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg (1995) 0.94
Psychogeriatrics and community care. Lancet (1975) 0.93
Surgical manipulation of primate cerebral arteries in established vasospasm. J Neurosurg (1991) 0.93
Two large glycosylated polypeptides found in myelinating oligodendrocytes but not in myelin. Proc Natl Acad Sci U S A (1986) 0.92
Structure of the human hexabrachion (tenascin) gene. Proc Natl Acad Sci U S A (1991) 0.92
Arterial wall changes in cerebral vasospasm. Neurosurgery (1989) 0.91
Inhibition of T cell activation by the extracellular matrix protein tenascin. J Immunol (1994) 0.91
Neuropsychological function in patients after subarachnoid hemorrhage. Neurosurgery (1987) 0.91
Pulmonary edema following fatal aneurysm rupture. J Neurosurg (1978) 0.91
The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage. Neurosurgery (1990) 0.91
Rapidity of compensatory lung growth following pneumonectomy in adult rats. J Appl Physiol Respir Environ Exerc Physiol (1979) 0.91
Cognition and metacognition at extreme altitudes on Mount Everest. J Exp Psychol Gen (1990) 0.91
Maintenance of isolated oligodendrocytes in long-term culture. Brain Res (1980) 0.89
Increased responsiveness of sensory neurons in the saphenous nerve of the streptozotocin-diabetic rat. J Neurophysiol (1992) 0.89
An Icelandic saga on a centralized healthcare database and democratic decision making. Nat Biotechnol (1999) 0.89
Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J Immunol (1987) 0.88
The role of linkage studies for common diseases. Curr Opin Genet Dev (2001) 0.88
Structure and chromosomal localization of the human gene for a brain form of prostaglandin D2 synthase. J Biol Chem (1992) 0.88
The vasorelaxation of cerebral arteries by carbon monoxide. Exp Biol Med (Maywood) (2001) 0.88
Knowledge of chlamydial infection among university students. Health Educ (1989) 0.88
Rate of heating as a determinant of hyperthermic cytotoxicity. Cancer Res (1981) 0.88
Cerebral vasospasm and free radicals. Free Radic Biol Med (1994) 0.87
The prevalence of polycystic ovaries in women with infertility. Hum Reprod (1999) 0.87
Molecular evolution of tau protein: implications for Alzheimer's disease. J Neurochem (1996) 0.87
Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein. J Neurosurg (1995) 0.86
Binding of hexabrachions to heparin and DNA. J Biol Chem (1989) 0.86
Developmental alterations in molecular weights of proteins in the human central nervous system that react with antibodies against myelin-associated glycoprotein. J Cell Biol (1984) 0.86
Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. J Neurosurg (1987) 0.86
Chromosomal localization of the human hexabrachion (tenascin) gene and evidence for recent reduplication within the gene. Genomics (1990) 0.86
Long-term survival after removal of metastatic malignant melanoma of the brain. Report of two cases. J Neurosurg (1968) 0.86
Intracellular mechanisms involved in the responses of cerebrovascular smooth-muscle cells to hemoglobin. J Neurosurg (1994) 0.85
Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. J Natl Cancer Inst (1982) 0.85
Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg (1995) 0.85